If You're A Risk-Taking Investor, Amicus Therapeutics, Inc. (NASDAQ:FOLD) Is Worth Taking A ...

Retrieved on: 2021-02-02 18:43:19

Tags for this article:

Click the tags to see associated articles and topics

If You're A Risk-Taking Investor, Amicus Therapeutics, Inc. (NASDAQ:FOLD) Is Worth Taking A .... View article details on hiswai:

Excerpt

Vanguard Group, Inc. (The), with 8.9% or 23.19 Million shares worth $327.41 Million as of Sep 29, 2020, holds the second largest percentage of ...

Article found on: marketingsentinel.com